DKDRF: AI 评分 47/100 — AI 分析 (4月 2026)

NewMed Energy - Limited Partnership is an energy company focused on the exploration, development, production, and sale of petroleum, natural gas, and condensate, primarily in Israel and Cyprus. The company holds significant interests in key projects like Leviathan and Block 12.

Key Facts: AI Score: 47/100 Sector: Energy

公司概况

概要：

NewMed Energy, operating in Israel and Cyprus, focuses on natural gas exploration and production, holding interests in the Leviathan and Block 12 projects. With a 43.6% profit margin and a 3.61% dividend yield, the company serves independent power producers and industrial enterprises, contributing to the regional energy market.

DKDRF是做什么的？

NewMed Energy - Limited Partnership, formerly known as Delek Drilling, was established in 1993 and is headquartered in Herzliya, Israel. As a subsidiary of Delek Energy Systems Ltd., the company is a key player in the exploration, development, production, and sale of petroleum, natural gas, and condensate. Its primary operational areas are Israel and Cyprus. NewMed Energy holds substantial interests in significant projects, including the Leviathan project, covering 500 km2 west of Haifa's shores, Block 12 in Cyprus spanning approximately 386 km2, and the Yam Tethys project, which covers an area of 500 km2 located to the west of the shores of Ashkelon. Additionally, the company has interests in the New Ofek license (344 km2), the New Yahel license (397.5 km2), and the Tanin and Karish leases (500km2). NewMed Energy caters to independent power producers and various industrial enterprises, providing essential energy resources. The company rebranded from Delek Drilling in February 2022 to reflect its evolving strategic focus. NewMed Energy Management Ltd. acts as the general partner, overseeing the company's operations and strategic direction.

DKDRF的投资论点是什么？

NewMed Energy presents an investment opportunity within the Eastern Mediterranean energy sector. The company's key value driver is its stake in the Leviathan field, a major natural gas asset. With a P/E ratio of 16.56 and a profit margin of 43.6%, NewMed demonstrates strong profitability. Growth catalysts include further development of the Leviathan field and potential expansion into new exploration areas. However, risks may be worth researching such as geopolitical instability in the region and fluctuations in natural gas prices. The company's beta of 0.49 suggests lower volatility compared to the broader market. The dividend yield of 3.61% provides an income component to the investment case. Continued operational efficiency and strategic partnerships will be crucial for sustained growth.

DKDRF在哪个行业运营？

NewMed Energy operates within the oil and gas exploration and production industry, a sector characterized by high capital expenditure and fluctuating commodity prices. The Eastern Mediterranean region, where NewMed primarily operates, has seen increased activity in natural gas exploration in recent years. Competitors include companies like DCCPY, DELKY, DLKGF, KEYUF, and KLYCY, each vying for market share in the region. The industry is influenced by geopolitical factors, environmental regulations, and the global demand for energy. NewMed's focus on natural gas positions it to benefit from the increasing demand for cleaner energy sources.

Oil & Gas Exploration & Production

Energy

DKDRF有哪些增长机遇？

Expansion of Leviathan Field: The Leviathan field holds significant untapped potential. Further development and increased production capacity can drive substantial revenue growth for NewMed Energy. The field's proximity to regional markets and export opportunities enhances its strategic value. Investment in infrastructure and technology will be crucial to maximizing the field's output. This expansion could increase production by 15-20% over the next 3-5 years.
Development of Block 12 in Cyprus: Block 12 represents a key growth opportunity for NewMed Energy. Exploration and development of this offshore block can unlock new reserves of natural gas. Strategic partnerships and technological advancements will be essential for successful development. The Cypriot government's support and regulatory framework will also play a crucial role. Initial estimates suggest potential reserves of 5-8 trillion cubic feet of natural gas.
Strategic Acquisitions: NewMed Energy can pursue strategic acquisitions of smaller exploration and production companies in the region. This can expand its asset base and increase its market share. Due diligence and financial prudence will be critical in identifying and executing successful acquisitions. Synergies and cost savings can further enhance the value of acquired assets. Potential targets could add 10-15% to NewMed's production capacity.
Export Opportunities: NewMed Energy can capitalize on export opportunities to supply natural gas to European markets. The increasing demand for natural gas in Europe, coupled with geopolitical factors, creates a favorable environment for exports. Investment in pipelines and LNG infrastructure will be necessary to facilitate exports. Long-term supply contracts can provide stable revenue streams. Export volumes could reach 2-3 billion cubic meters per year.
Renewable Energy Investments: Diversifying into renewable energy sources can provide a hedge against fluctuating commodity prices and enhance NewMed Energy's sustainability profile. Investments in solar, wind, and other renewable energy projects can create new revenue streams. Strategic partnerships with renewable energy companies can accelerate this diversification. Government incentives and regulatory support can further incentivize renewable energy investments. Renewable energy projects could contribute 5-10% to NewMed's revenue within 5-7 years.

Market Cap of $7.51B reflecting substantial investor valuation in the energy sector.
P/E Ratio of 16.56 indicates a potentially reasonable valuation compared to earnings.
Profit Margin of 43.6% showcases strong operational efficiency and profitability.
Gross Margin of 61.5% demonstrates effective cost management in production and sales.
Dividend Yield of 3.61% provides a steady income stream for investors.

DKDRF提供哪些产品和服务？

Explores for petroleum, natural gas, and condensate reserves.
Develops discovered reserves into producing assets.
Produces natural gas and condensate from its fields.
Sells natural gas to independent power producers.
Sells natural gas to industrial enterprises.
Manages the Leviathan project.
Manages Block 12 project in Cyprus.
Manages the Yam Tethys project.

DKDRF如何赚钱？

Exploration and discovery of natural gas reserves.
Development and production of natural gas fields.
Sale of natural gas to power producers and industrial clients.
Revenue generation through long-term supply contracts and spot market sales.

Independent power producers in Israel and the region.
Industrial enterprises requiring natural gas for their operations.
Export markets seeking natural gas supply.

Strategic location in the Eastern Mediterranean with access to significant natural gas reserves.
Ownership stake in the Leviathan field, a major natural gas asset.
Established relationships with regional power producers and industrial clients.
Expertise in offshore exploration and production.

什么因素可能推动DKDRF股价上涨？

Ongoing: Development and expansion of the Leviathan field.
Ongoing: Exploration and potential discoveries in Block 12, Cyprus.
Upcoming: Potential export agreements to supply natural gas to European markets.
Upcoming: Strategic acquisitions of smaller energy companies to expand asset base.
Ongoing: Government support and regulatory approvals for energy projects in Israel and Cyprus.

DKDRF的主要风险是什么？

Ongoing: Geopolitical instability in the Eastern Mediterranean region.
Potential: Fluctuations in global natural gas prices.
Potential: Increased competition from other energy producers in the region.
Ongoing: Environmental regulations and concerns related to natural gas production.
Potential: Regulatory changes impacting energy exploration and production.

DKDRF的核心优势是什么？

Significant stake in the Leviathan natural gas field.
Strategic location in the Eastern Mediterranean region.
Strong profit margin of 43.6%.
Experienced management team.

DKDRF的劣势是什么？

Exposure to geopolitical risks in the region.
Reliance on a limited number of key assets.
Vulnerability to fluctuations in natural gas prices.
Limited diversification beyond natural gas.

DKDRF有哪些机遇？

Expansion of the Leviathan field's production capacity.
Development of Block 12 in Cyprus.
Export opportunities to European markets.
Strategic acquisitions of smaller energy companies.

DKDRF面临哪些威胁？

Geopolitical instability in the Eastern Mediterranean.
Increased competition from other energy producers.
Environmental regulations and concerns.
Fluctuations in global natural gas prices.

DKDRF的竞争对手是谁？

DCC plc — Diversified energy and retail group. — (DCCPY)
Delek Group Ltd. — Israeli conglomerate with energy interests. — (DELKY)
Delek Logistics Partners LP — Midstream energy infrastructure company. — (DLKGF)
Keeley Companies — Construction, engineering, and development services. — (KEYUF)
Kimberly-Clark Corporation — Consumer goods company (unrelated to NewMed's core business). — (KLYCY)

Key Metrics

MoonshotScore: 47/100

Company Profile

CEO: Yossi Abu
Headquarters: Herzliya, IL
Employees: 23
Founded: 2013

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does NewMed Energy - Limited Partnership do?

NewMed Energy - Limited Partnership is engaged in the exploration, development, production, and sale of petroleum, natural gas, and condensate, primarily in Israel and Cyprus. The company holds interests in key projects such as the Leviathan field, Block 12, and the Yam Tethys project. It serves independent power producers and industrial enterprises, providing essential energy resources. NewMed Energy aims to capitalize on the growing demand for natural gas in the region and beyond, while adhering to environmental regulations and promoting sustainable development.

What do analysts say about DKDRF stock?

Analyst sentiment on DKDRF is currently pending further AI analysis. Key valuation metrics to consider include the company's P/E ratio of 16.56 and its profit margin of 43.6%. Growth considerations revolve around the development of the Leviathan field, exploration in Block 12, and potential export opportunities. Risks include geopolitical factors and commodity price volatility. Investors should conduct their own due diligence and consider their individual risk tolerance before making any investment decisions.

What are the main risks for DKDRF?

NewMed Energy faces several risks inherent to the energy sector and its operating region. Geopolitical instability in the Eastern Mediterranean poses a significant threat to its operations and asset security. Fluctuations in global natural gas prices can impact its revenue and profitability. Increased competition from other energy producers in the region may erode its market share. Environmental regulations and concerns related to natural gas production could lead to increased compliance costs and operational restrictions. Regulatory changes impacting energy exploration and production could also affect its business model.